These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21160412)

  • 1. Association of aging and survival in a large HIV-infected cohort on antiretroviral therapy.
    Bakanda C; Birungi J; Mwesigwa R; Ford N; Cooper CL; Au-Yeung C; Chan K; Nachega JB; Wood E; Hogg RS; Dybul M; Mills EJ
    AIDS; 2011 Mar; 25(5):701-5. PubMed ID: 21160412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in Uganda.
    Mills EJ; Bakanda C; Birungi J; Mwesigwa R; Chan K; Ford N; Hogg RS; Cooper C
    AIDS; 2011 Mar; 25(6):851-5. PubMed ID: 21330903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive multifocal leukoencephalopathy: improved survival of human immunodeficiency virus-infected patients in the protease inhibitor era.
    Dworkin MS; Wan PC; Hanson DL; Jones JL
    J Infect Dis; 1999 Sep; 180(3):621-5. PubMed ID: 10438348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 subtype E progression among northern Thai couples: traditional and non-traditional predictors of survival.
    Costello C; Nelson KE; Suriyanon V; Sennun S; Tovanabutra S; Heilig CM; Shiboski S; Jamieson DJ; Robison V; Rungruenthanakit K; Duerr A
    Int J Epidemiol; 2005 Jun; 34(3):577-84. PubMed ID: 15737969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
    Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
    Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
    Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An algorithm-based genotypic resistance score is associated with clinical outcome in HIV-1-infected adults on antiretroviral therapy.
    Ormaasen V; Sandvik L; Asjø B; Holberg-Petersen M; Gaarder PI; Bruun JN
    HIV Med; 2004 Nov; 5(6):400-6. PubMed ID: 15544691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
    Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
    HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score.
    Mocroft A; Ledergerber B; Zilmer K; Kirk O; Hirschel B; Viard JP; Reiss P; Francioli P; Lazzarin A; Machala L; Phillips AN; Lundgren JD;
    AIDS; 2007 Sep; 21(14):1867-75. PubMed ID: 17721094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in antiretroviral treatment outcomes among HIV-infected adults in an urban Tanzanian setting.
    Hawkins C; Chalamilla G; Okuma J; Spiegelman D; Hertzmark E; Aris E; Ewald T; Mugusi F; Mtasiwa D; Fawzi W
    AIDS; 2011 Jun; 25(9):1189-97. PubMed ID: 21505309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART.
    Jevtović Dj; Vanovac V; Veselinović M; Salemović D; Ranin J; Stefanova E
    Biomed Pharmacother; 2009 Sep; 63(8):561-5. PubMed ID: 19026516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The benefit of supplementary feeding for wasted Malawian adults initiating ART.
    van Oosterhout JJ; Ndekha M; Moore E; Kumwenda JJ; Zijlstra EE; Manary M
    AIDS Care; 2010 Jun; 22(6):737-42. PubMed ID: 20467944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased health care utilization and increased antiretroviral use in HIV-infected individuals with mental health disorders.
    Mijch A; Burgess P; Judd F; Grech P; Komiti A; Hoy J; Lloyd JH; Gibbie T; Street A
    HIV Med; 2006 May; 7(4):205-12. PubMed ID: 16630032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HIV agents. Is it age or AIDS? Study finds risk of dementia increases with age.
    TreatmentUpdate; 2004; 16(5):1-2. PubMed ID: 17216839
    [No Abstract]   [Full Text] [Related]  

  • 15. Valproic acid adjunctive therapy for HIV-associated cognitive impairment: a first report.
    Schifitto G; Peterson DR; Zhong J; Ni H; Cruttenden K; Gaugh M; Gendelman HE; Boska M; Gelbard H
    Neurology; 2006 Mar; 66(6):919-21. PubMed ID: 16510768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood lipid changes at long-term antiretroviral treatment].
    Snopková S; Jarkovský J; Matýsková M; Povolná K; Polák P; Cvanová M; Husa P
    Vnitr Lek; 2011 May; 57(5):463-71. PubMed ID: 21695927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of malnutrition on survival and the CD4 count response in HIV-infected patients starting antiretroviral therapy.
    Paton NI; Sangeetha S; Earnest A; Bellamy R
    HIV Med; 2006 Jul; 7(5):323-30. PubMed ID: 16945078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study.
    Furrer H; Egger M; Opravil M; Bernasconi E; Hirschel B; Battegay M; Telenti A; Vernazza PL; Rickenbach M; Flepp M; Malinverni R
    N Engl J Med; 1999 Apr; 340(17):1301-6. PubMed ID: 10219064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
    Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use.
    Kwong GP; Ghani AC; Rode RA; Bartley LM; Cowling BJ; da Silva B; Donnelly CA; van Sighem AI; Cameron DW; Danner SA; de Wolf F; Anderson RM
    AIDS; 2006 Oct; 20(15):1941-50. PubMed ID: 16988515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.